Video

ACO Growth and Specialty Pharmacies

Author(s):

Lauren Santye, Assistant Editor

Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses how specialty pharmacies will be impacted by the growth of accountable care organizations.

Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses how specialty pharmacies will be impacted by the growth of accountable care organizations.

Related Videos
Image credit: JJAVA | stock.adobe.com
Related Content
Composition with pills of Bayer Aspirin
April 17th 2025

High-Dose Aspirin With IVIG Does Not Meaningfully Reduce Coronary Artery Lesions in Children With Kawasaki Disease

Luke Halpern, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Gut health -- Image credit: sdecoret | stock.adobe.com
April 16th 2025

Essential Immune Cells in Intestine Cause Gut Inflammation, Allergic Responses to Foods When Absent

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Health care professional hands holding a hepatitis liver -- Image credit: mi_viri | stock.adobe.com
April 15th 2025

Study: Hepatic PTPRD Expression Impaired in Etiologies of Chronic Liver Disease Associated With Metabolic Disease

Gillian McGovern, Associate Editor
Pharmacist in specialty pharmacy preparing oral oncolytics -- Image credit: Monet | stock.adobe.com
April 15th 2025

Outcomes of Pharmacist-Driven Clinical Interventions in a Medically Integrated Oncology Specialty Pharmacy Practice

Natalie Kaufman, PharmD Nicole Bentivegna, PharmD, BCOP Roger Orr, PharmD, BCOP